Cited by 430Complement system in diseasesBiomarkers in Disease MechanismsCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Complement and Its Receptors: New Insights into Human Disease

Open access

Holers, V. Michael·2014·Annual Review of Immunology

DOI 10.1146/annurev-immunol-032713-120154

Open this paper in CoChat — free account Open PDF

Abstract

Although new activation and regulatory mechanisms are still being identified, the basic architecture of the complement system has been known for decades. Two major roles of complement are to control certain bacterial infections and to promote clearance of apoptotic cells. In addition, although inappropriate complement activation has long been proposed to cause tissue damage in human inflammatory and autoimmune diseases, whether this is indeed true has been uncertain. However, recent studies in humans, especially those using newly available biological therapeutics, have now clearly demonstrated the pathophysiologic importance of the complement system in several rare diseases. Beyond these conditions, recent genetic studies have strongly supported an injurious role for complement in a wide array of human inflammatory, degenerative, and autoimmune diseases. This review includes an overview of complement activation, regulatory, and effector mechanisms. It then focuses on new understandings gained from genetic studies, ex vivo analyses, therapeutic trials, and animal models as well as on new research opportunities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-immunol-032713-120154

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 3×
“Additionally, the recently recognized roles of complement in homeostasis point to several nontraditional functions that bridge immunity and developmental biology (12).”
BackgroundInfluential
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,711
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M. S., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 976
MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEM
Müller‐Eberhard, H. J. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001541 · Cited by 856
Discovery and Development of the Complement Inhibitor Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778 · cited 2×
“On red blood cells, the absence of DAF allows alternative pathway–initiated complement activation by C3 and C5 convertases; the absence of CD59 allows activated C5 to proceed to form the MAC, resulting in intravascular hemolysis (102, 103).”
Background
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C. J., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 770
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F. T., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 719
Complement and coagulation: strangers or partners in crime?
Markiewski, M., Nilsson, B., Ekdahl, K., Mollnes, T., & Lambris, J. D. (2007) · Trends in immunology · doi:10.1016/j.it.2007.02.006 · Cited by 664
Drusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 650
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
Phan, T. G., Grigorova, I., Okada, T., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1494 · Cited by 644
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens
Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L. J., Scales, S. J., Ghilardi, N., & Campagne, M. V. L. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 629
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 608
THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITY
Carroll, M. C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.545 · Cited by 602
Genetic insights into common pathways and complex relationships among immune-mediated diseases
Parkes, M., Cortés, A., van Heel, D. A., & Brown, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3502 · Cited by 540
Structure and biology of complement protein C3, a connecting link between innate and acquired immunity
Sahu, A., & Lambris, J. D. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800103.x · Cited by 533
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Self-citation
Control of the Complement System
Liszewski, M. K., FARRIES, T. C., Lublin, D. M., Rooney, I. A., & Atkinson, J. P. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60868-8 · Cited by 500
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration
Hughes, A. E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., & Chakravarthy, U. (2006) · Nature Genetics · doi:10.1038/ng1890 · Cited by 467
The Regulators of Complement Activation (RCA) Gene Cluster
Hourcade, D. E., Holers, V. M., & Atkinson, J. P. (1989) · Advances in immunology · doi:10.1016/s0065-2776(08)60697-5 · Cited by 439
Self-citation
The proinflammatory mediators C3a and C5a are essential for liver regeneration
Strey, C. W., Markiewski, M., Mastellos, D., Tudoran, R., Spruce, L. A., Greenbaum, L. E., & Lambris, J. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030374 · Cited by 436
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Pittock, S. J., Lennon, V. A., McKeon, A. B., Mandrekar, J. N., Weinshenker, B. G., Lucchinetti, C. F., O’Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 401
Regulation of Toll-like receptor–mediated inflammatory response by complement in vivo
Zhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J. D., Wetsel, R. A., Miwa, T., & Song, W. (2007) · Blood · doi:10.1182/blood-2006-12-063636 · Cited by 378
A Critical Role for Complement in Maintenance of Self-Tolerance
Продеус, А. П., Goerg, S., Shen, L.-M., Pozdnyakova, O., Chu, L. P., Alicot, E. M., Goodnow, C. C., & Carroll, M. C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80669-x · Cited by 373
C3 glomerulopathy: a new classification
Fakhouri, F., Frémeaux‐Bacchi, V., Noël, L., Cook, H. T., & Pickering, M. C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.85 · Cited by 361
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
Risitano, A. M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Alfinito, F., Camera, A., Gianfaldoni, G., et al. (2009) · Blood · doi:10.1182/blood-2008-11-189944 · Cited by 361
A role for the C3a anaphylatoxin receptor in the effector phase of asthma
Humbles, A. A., Lu, B., Nilsson, C. A., Lilly, C. M., Israel, E., Fujiwara, Y., Gerard, N. P., & Gerard, C. J. (2000) · Nature · doi:10.1038/35023175 · Cited by 353
Extrahepatic complement biosynthesis: where, when and why?
Morgan, B. P., & Gasque, P. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-890.x · Cited by 351
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
Gale, D. P., de Jorge, E. G., Cook, H. T., Martínez‐Barricarte, R., Hadjisavvas, A., McLean, A. G., Pusey, C. D., Pierides, A., Kyriacou, K. C., Athanasiou, Y., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60670-8 · Cited by 335
Complement driven by conformational changes
Gros, P., Milder, F. J., & Janssen, B. J. C. (2007) · Nature reviews. Immunology · doi:10.1038/nri2231 · Cited by 324
Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
Strainic, M. G., Shevach, E. M., An, F., Lin, F., & Medof, M. E. (2012) · Nature Immunology · doi:10.1038/ni.2499 · Cited by 308
C1q, Autoimmunity and Apoptosis
Botto, M. (2002) · Immunobiology · doi:10.1078/0171-2985-00141 · Cited by 294
Dimerization of complement factor H-related proteins modulates complement activation in vivo
de Jorge, E. G., Caesar, J. J. E., Malik, T. H., Patel, M., Colledge, M., Johnson, S., Hakobyan, S., Morgan, B. P., Harris, C. L., Pickering, M. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219260110 · Cited by 290
Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort
Salmon, J. E., Heuser, C. C., Triebwasser, M. P., Liszewski, M. K., Kavanagh, D., Roumenina, L. T., Branch, D. W., Goodship, T. H. J., Frémeaux‐Bacchi, V., & Atkinson, J. P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001013 · Cited by 288
Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains
Pickering, M. C., de Jorge, E. G., Martínez‐Barricarte, R., Recalde, S., García‐Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 281
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Hawlisch, H., Belkaid, Y., Bälder, R., Hildeman, D. A., Gerard, C. J., & Köhl, J. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.006 · Cited by 277
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer’s Disease
Fonseca, M. I., Ager, R. R., Chu, S.-H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901005 · Cited by 268
Complement in human diseases: Lessons from complement deficiencies
Botto, M., Kirschfink, M., Macor, P., Pickering, M. C., Würzner, R., & Tedesco, F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.029 · Cited by 264
Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury
Jordan, J. E., Montalto, M. C., & Stahl, G. L. (2001) · Circulation · doi:10.1161/hc3601.095578 · Cited by 263
Factor H family proteins and human diseases
Józsi, M., & Zipfel, P. F. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.008 · Cited by 254
Factor H family proteins: on complement, microbes and human diseases
Zipfel, P. F., Skerka, C., Hellwage, J., Jokiranta, S. T., Meri, S., Brade, V., Kraiczy, P., Noris, M., & Remuzzi, G. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300971 · Cited by 252
Structural basis for engagement by complement factor H of C3b on a self surface
Morgan, H. P., Schmidt, C. Q., Guariento, M., Blaum, B. S., Gillespie, D., Herbert, A. P., Kavanagh, D., Mertens, H. D. T., Svergun, D. I., Johansson, C. M., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2018 · Cited by 249
C1 Inhibitor and Hereditary Angioneurotic Edema
Davis, A. E. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.003115 · Cited by 247
Complement receptors and phagocytosis
Brown, E. J. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90081-b · Cited by 244
The Role of Complement in B Cell Activation and Tolerance
Carroll, M. C. (1999) · Advances in immunology · doi:10.1016/s0065-2776(08)60908-6 · Cited by 240
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk
Heurich, M., Martínez‐Barricarte, R., Francis, N., Roberts, D. L., de Córdoba, S. R., Morgan, B. P., & Harris, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019338108 · Cited by 237
Microbial Hijacking of Complement–Toll-Like Receptor Crosstalk
Wang, M., Krauss, J. L., Domon, H., Hosur, K. B., Liang, S., Magotti, P., Triantafilou, M., Triantafilou, K., Lambris, J. D., & Hajishengallis, G. (2010) · Science Signaling · doi:10.1126/scisignal.2000697 · Cited by 229
The Amplification Loop of the Complement Pathways
Lachmann, P. J. (2009) · Advances in immunology · doi:10.1016/s0065-2776(08)04004-2 · Cited by 220
C1 Inhibitor And Hereditary Angioneurotic Edema
Davis, A. E. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.595 · Cited by 218
Structure, function and cellular expression of complement anaphylatoxin receptors
Wetsel, R. A. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80028-x · Cited by 211
The CD46-Jagged1 interaction is critical for human TH1 immunity
Friec, G. L., Sheppard, D., Whiteman, P., Karsten, C. M., Shamoun, S. A.-T., Laing, A. G., Bugeon, L., Dallman, M. J., Melchionna, T., Chillakuri, C., et al. (2012) · Nature Immunology · doi:10.1038/ni.2454 · Cited by 204
Complement inhibitor C4b-binding protein—friend or foe in the innate immune system?
Blom, A. M., Villoutreix, B. O., & Dahlbäck, B. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.12.002 · Cited by 202
C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation
Tortajada, A., Yébenes, H., Abarrategui-Garrido, C., Anter, J., García-Fernández, J., Martínez‐Barricarte, R., Alba‐Domínguez, M., Malik, T. H., Bedoya, R., Pérez, R. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68280 · Cited by 197
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli–induced hemolytic uremic syndrome
Ståhl, A.-L., Sartz, L., & Karpman, D. (2011) · Blood · doi:10.1182/blood-2010-09-309161 · Cited by 197
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues
Cooke, T. D. V., Hurd, E. R., Jasin, H. E., Bienenstock, J., & Ziff, M. (1975) · Arthritis & Rheumatism · doi:10.1002/art.1780180603 · Cited by 194
Translational Mini-Review Series on Complement Factor H: Renal diseases associated with complement factor H: novel insights from humans and animals
Pickering, M. C., & Cook, H. T. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03574.x · Cited by 188
A protective role for innate immunity in systemic lupus erythematosus
Carroll, M. (2004) · Nature reviews. Immunology · doi:10.1038/nri1456 · Cited by 187
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis
Silasi‐Mansat, R., Zhu, H., Popescu, N. I., Peer, G. T., Sfyroera, G., Magotti, P., Ivanciu, L., Lupu, C., Mollnes, T. E., Taylor, F. B., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269746 · Cited by 186
Carboxypeptidase N: a pleiotropic regulator of inflammation
Matthews, K. R. W., Mueller‐Ortiz, S. L., & Wetsel, R. A. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.002 · Cited by 185
Oxidation and age-related macular degeneration: insights from molecular biology
Khandhadia, S., & Lotery, A. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000164x · Cited by 183
Contribution of the innate immune system to autoimmune myocarditis: a role for complement
Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K. M., Schlichting, J., Tretter, T., Fairweather, D., Holers, V. M., & Rose, N. R. (2001) · Nature Immunology · doi:10.1038/90686 · Cited by 175
Self-citation
BAFF and selection of autoreactive B cells
Liu, Z., & Davidson, A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.004 · Cited by 171
Initiation of complement activation
Lachmann, P. J., & Hughes-Jones, N. C. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893018 · Cited by 164
The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases
Karsten, C. M., & Köhl, J. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.015 · Cited by 164
Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.
Davies, K. A., Peters, A. M., Beynon, H. L., & Walport, M. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116090 · Cited by 155
Local production of complement proteins in rheumatoid arthritis synovium
Neumann, E., Barnum, S. R., Tarner, I. H., Echols, J., Fleck, M., Judex, M., Kullmann, F., Mountz, J. D., Schölmerich, J., Gay, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10183 · Cited by 155
Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis
Banda, N. K., Thurman, J. M., Kraus, D., Wood, A., Carroll, M. C., Arend, W. P., & Holers, V. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1904 · Cited by 153
Self-citation
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Ogembo, J. G., Kannan, L., Ghiran, I. C., Nicholson-Weller, A., Finberg, R. W., Tsokos, G. C., & Fingeroth, J. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.023 · Cited by 153
The tick-over theory revisited: Is C3 a contact-activated protein?
Nilsson, B., & Ekdahl, K. N. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.008 · Cited by 149
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
Fang, C. J., Frémeaux‐Bacchi, V., Liszewski, M. K., Pianetti, G., Noris, M., Goodship, T. H. J., & Atkinson, J. P. (2007) · Blood · doi:10.1182/blood-2007-04-084533 · Cited by 148
Ficolins: Novel pattern recognition molecules of the innate immune response
Runza, V., Schwaeble, W., & Männel, D. N. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.10.009 · Cited by 142
Is complement good or bad for cancer patients? A new perspective on an old dilemma
Markiewski, M. M., & Lambris, J. D. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.04.002 · Cited by 139
Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice
Banda, N. K., Hyatt, S., Antonioli, A. H., White, J. T., Glogowska, M. J., Takahashi, K., Merkel, T. J., Stahl, G. L., Mueller‐Ortiz, S. L., Wetsel, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102310 · Cited by 137
Self-citation
A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice
He, S., Atkinson, C., Qiao, F., Cianflone, K., Chen, X., & Tomlinson, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38289 · Cited by 135
The role of complement system in ocular diseases including uveitis and macular degeneration
Jha, P., Bora, P. S., & Bora, N. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.145 · Cited by 134
Human complement control and complement evasion by pathogenic microbes – Tipping the balance
Zipfel, P. F., Hallström, T., & Riesbeck, K. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.222 · Cited by 134
Cutting Edge: Localization of the Host Recognition Functions of Complement Factor H at the Carboxyl-Terminal: Implications for Hemolytic Uremic Syndrome
Pangburn, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4702 · Cited by 133
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H–deficient mice
Rose, K. L., Paixão-Cavalcante, D., Fish, J., Manderson, A. P., Malik, T. H., Bygrave, A. E., Lin, T., Sacks, S. H., Walport, M. J., Cook, H. T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32525 · Cited by 132
C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion
Thurman, J. M., Lenderink, A. M., Royer, P. A., Coleman, K. E., Zhou, J., Lambris, J. D., Nemenoff, R. A., Quigg, R. J., & Holers, V. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1819 · Cited by 131
Self-citation
Mannan-binding lectin?a soluble pattern recognition molecule
Gadjeva, M. G. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.015 · Cited by 131
Endothelial Oxidative Stress Activates the Lectin Complement Pathway
Collard, C. D., Montalto, M. C., Reenstra, W. R., Buras, J. A., & Stahl, G. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61779-8 · Cited by 129
A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy
Malik, T. H., Lavin, P., de Jorge, E. G., Vernon, K. A., Rose, K. L., Patel, M., de Leeuw, M. A., Neary, J. J., Conlon, P. J., Winn, M. P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020166 · Cited by 129
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sohn, J.-H., Dhaulakhandi, D. B., Kaplan, H. J., & Bora, P. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1872 · Cited by 124
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
Schulz, C., Engelmann, B., & Maßberg, S. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12261 · Cited by 124
Effects of complement factor D deficiency on the renal disease of MRL/lpr mice
Elliott, M. K., Jarmi, T., Ruiz, P., Xu, Y., Holers, V. M., & Gilkeson, G. S. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00371.x · Cited by 118
Self-citation
A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
Cashman, S. M., Ramo, K., & Kumar-Singh, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019078 · Cited by 118
Progress and Trends in Complement Therapeutics
Ricklin, D., & Lambris, J. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_1 · Cited by 114
Complement dysregulation and disease: From genes and proteins to diagnostics and drugs
de Córdoba, S. R., Tortajada, A., Harris, C. L., & Morgan, B. P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.021 · Cited by 113
Functions of C5a receptors
Ward, P. A. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0442-7 · Cited by 112
Pathogenic Complement Activation in Collagen Antibody- Induced Arthritis in Mice Requires Amplification by the Alternative Pathway
Banda, N. K., Takahashi, K., Wood, A., Holers, V. M., & Arend, W. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4101 · Cited by 112
Self-citation
Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production
Fang, C., Zhang, X., Miwa, T., & Song, W. (2009) · Blood · doi:10.1182/blood-2009-01-198283 · Cited by 111
Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging
Fu, W., Wojtkiewicz, G. R., Weissleder, R., Benoist, C. O., & Mathis, D. J. (2012) · Nature Immunology · doi:10.1038/ni.2233 · Cited by 110
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
Han, W., Xin, Z., Zhao, Z., Bao, W., Lin, X., Yin, B., Zhao, J., Yuan, J., Qiang, B., & Peng, X. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61820 · Cited by 108
Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation
Bälder, R., Fuchs, B., Bautsch, W., Zwirner, J., Köhl, J., Hoymann, H.-G., Glaab, T., Erpenbeck, V. J., Krug, N., & Braun, A. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.783 · Cited by 106
Epidemiology of rheumatoid arthritis
Silman, A. J. (1994) · Apmis · doi:10.1111/j.1699-0463.1994.tb05226.x · Cited by 104
The complement system as a therapeutic target in autoimmunity
Holers, V. M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00034-2 · Cited by 101
Self-citation
Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson, D. A., Ahearn, J. M., Matsumoto, A. K., & Fearon, D. T. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.5.1083 · Cited by 100
Crosstalk between Complement and Toll-Like Receptors
Song, W. (2011) · Toxicologic Pathology · doi:10.1177/0192623311428478 · Cited by 99
CD46 in innate and adaptive immunity: an update
Cardone, J., Friec, G. L., & Kemper, C. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04400.x · Cited by 98
The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies
Li, K., Sacks, S. H., & Zhou, W. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.006 · Cited by 98
Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation
Takahashi, K., Chang, W., Takahashi, M., Pavlov, V. I., Ishida, Y., Bonte, L. L., Shi, L., Fujita, T., Stahl, G. L., & Cott, E. M. V. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.02.005 · Cited by 96
Properdin: New roles in pattern recognition and target clearance
Kemper, C., & Hourcade, D. E. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.034 · Cited by 95
Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes
Józsi, M., Prechl, J., Bajtay, Z., & Erdei, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2782 · Cited by 95
Complement activation and inhibition in experimental models of arthritis
Linton, S. M., & Morgan, B. P. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00113-3 · Cited by 94
The alternative pathway of complement in disease: opportunities for therapeutic targeting
Holers, V. M. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.012 · Cited by 92
Self-citation
Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab
Schmidtko, J., Peine, S., Housseini, Y. E., Pascual, M. A., & Meier, P. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.028 · Cited by 92
Innate Autoimmunity
Carroll, M. C., & Holers, V. M. (2005) · Advances in immunology · doi:10.1016/s0065-2776(04)86004-8 · Cited by 90
Self-citation
Detection of complement activation using monoclonal antibodies against C3d
Thurman, J. M., Kulik, L. N., Orth, H. N., Wong, M., Renner, B., Sargsyan, S. A., Mitchell, L. M., Hourcade, D. E., Hannan, J. P., Kovacs, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65861 · Cited by 88
Self-citation
Administration of a Soluble Recombinant Complement C3 Inhibitor Protects Against Renal Disease in MRL/lpr Mice
Bao, L., Haas, M., Kraus, D., Hack, B. K., Rakstang, J. K., Holers, V. M., & Quigg, R. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051597.27127.a1 · Cited by 88
Self-citation
Targeted inhibition of complement activation prevents features of preeclampsia in mice
Qing, X., Redecha, P. B., Burmeister, M. A., Tomlinson, S., D’Agati, V. D., Davisson, R. L., & Salmon, J. E. (2010) · Kidney International · doi:10.1038/ki.2010.393 · Cited by 86
Complement fragments C3a and C5a: The salt and pepper of the immune response
Sacks, S. H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040355 · Cited by 83
Complement Factor H–ligand interactions: Self-association, multivalency and dissociation constants
Perkins, S. J., Nan, R., Li, K., Khan, S., & Miller, A. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.10.003 · Cited by 82
Extrahepatic synthesis of complement proteins in inflammation
Laufer, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00044-x · Cited by 81
‘‘Homologous restriction’’ in complement lysis: roles of membrane complement regulators
Morgan, B. P., van den Berg, C. W., & Harris, C. L. (2005) · Xenotransplantation · doi:10.1111/j.1399-3089.2005.00237.x · Cited by 81
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
Song, J. J., Hwang, I., Cho, K. H., Garcia, M. A., Kim, A. J., Wang, T. H., Lindström, T. M., Lee, A. T., Nishimura, T., Zhao, L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46387 · Cited by 80
Complement Diagnostics: Concepts, Indications, and Practical Guidelines
Nilsson, B., & Ekdahl, K. N. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/962702 · Cited by 80
gC1q Receptor Ligation Selectively Down-Regulates Human IL-12 Production through Activation of the Phosphoinositide 3-Kinase Pathway
Waggoner, S. N., Cruise, M. W., Kassel, R., & Hahn, Y. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4706 · Cited by 80
The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice
Sekine, H., Kinser, T. T. H., Qiao, F., Martinez, E., Paulling, E. E., Ruiz, P., Gilkeson, G. S., & Tomlinson, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30222 · Cited by 78
Complement factor H related proteins in immune diseases
Skerka, C., & Zipfel, P. F. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.021 · Cited by 78
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders
Risitano, A. M. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.014 · Cited by 78
Interactions of the humoral pattern recognition molecule PTX3 with the complement system
Doni, A., Garlanda, C., Bottazzi, B., Meri, S., Garred, P., & Mantovani, A. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.004 · Cited by 72
Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site
Perkins, S. J., & Goodship, T. H. J. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5337 · Cited by 72
Mammalian lectins in activation and clearance mechanisms involving the complement system
Reid, K. B. M., & TURNER, M. W. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf01837363 · Cited by 68
Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner
Joseph, K., Kulik, L. N., Coughlin, B. A., Kunchithapautham, K., Bandyopadhyay, M., Thiel, S., Thielens, N. M., Holers, V. M., & Rohrer, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421891 · Cited by 67
Self-citation
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization
Rohrer, B., Coughlin, B., Kunchithapautham, K., Long, Q., Tomlinson, S., Takahashi, K., & Holers, V. M. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.016 · Cited by 62
Self-citation
Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases
Happonen, K. E., Heinegård, D. K., Saxne, T., & Blom, A. M. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.013 · Cited by 56
Polyanion-Induced Self-Association of Complement Factor H
Pangburn, M. K., Rawal, N., Cortés, C., Alam, M. N., Ferreira, V. P., & Atkinson, M. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1061 · Cited by 53
Complement C2 Receptor Inhibitor Trispanning: A Novel Human Complement Inhibitory Receptor
Inal, J. M., Hui, K., Miot, S., Lange, S., Ramirez, M. I., Schneider, B., Krueger, G. R. F., & Schifferli, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.356 · Cited by 51
Clinical Manifestations of Paroxysmal Nocturnal Hemoglobinuria: Present State and Future Problems
Rosse, W. F., & Nishimura, J. (2003) · International Journal of Hematology · doi:10.1007/bf02983209 · Cited by 51
The dual role of complement in the progression of renal disease in NZB/W F1 mice and alternative pathway inhibition
Sekine, H., Ruiz, P., Gilkeson, G. S., & Tomlinson, S. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.015 · Cited by 51
CR2-Mediated Targeting of Complement Inhibitors: Bench-to-Bedside Using a Novel Strategy for Site-Specific Complement Modulation
Holers, V. M., Rohrer, B., & Tomlinson, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_9 · Cited by 50
Self-citation
Macrophage-Derived Complement Component C4 Can Restore Humoral Immunity in C4-Deficient Mice
Gadjeva, M. G., Verschoor, A., Brockman, M. A., Jezak, H., Shen, L. M., Knipe, D. M., & Carroll, M. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5489 · Cited by 50
Complement receptors and the shaping of the natural antibody repertoire
Holers, V. M. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0186-y · Cited by 49
Self-citation
Manipulating the mediator: Modulation of the alternative complement pathway C3 convertase in health, disease and therapy
Ricklin, D. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.016 · Cited by 49
The role of complement in mAb-based therapies of cancer
Taylor, R. P., & Lindorfer, M. A. (2013) · Methods · doi:10.1016/j.ymeth.2013.07.027 · Cited by 46
Bride and groom in systemic inflammation – The bells ring for complement and Toll in cooperation
Barratt‐Due, A., Pischke, S. E., Brekke, O., Thorgersen, E. B., Nielsen, E. W., Espevik, T., Huber-Lang, M. S., & Mollnes, T. E. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.019 · Cited by 40
Sushi domain‐containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase
Holmquist, E., Okrój, M., Nodin, B., Jirström, K., & Blom, A. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-222042 · Cited by 38
Complement Involvement in Neovascular Ocular Diseases
Yanai, R., Thanos, A., & Connor, K. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_10 · Cited by 35
Translational Mini-Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
Noris, M., & Remuzzi, G. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03558.x · Cited by 35
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases
Nester, C., & Brophy, P. D. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32835df4a3 · Cited by 34
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer
Elvington, M. L., Huang, Y., Morgan, B. P., Qiao, F., van Rooijen, N., Atkinson, C., & Tomlinson, S. (2012) · Blood · doi:10.1182/blood-2011-10-383232 · Cited by 34
CR1/CR2 Deficiency Alters IgG3 Autoantibody Production and IgA Glomerular Deposition in the MRL/lprModel of SLE
Boackle, S. A., Culhane, K. K., Brown, J. M., Haas, M., Bao, L., Quigg, R. J., & Holers, V. M. (2004) · Autoimmunity · doi:10.1080/08916930410001685063 · Cited by 32
Self-citation
Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?
Calero, I., & Sanz, I. (2010) · PubMed · Cited by 27
Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens
Kuhn, K. A., Cozine, C. L., Tomooka, B. H., Robinson, W. H., & Holers, V. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.036 · Cited by 26
Self-citation
Rheumatoid arthritis
Silman, A. J., & Hochberg, M. C. (1993) · doi:10.1093/oso/9780192623560.003.0002 · Cited by 17
Lessons from an anti-DNA autoantibody
Cohen-Solal, J. F. G., & Diamond, B. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.003 · Cited by 16
Putting the structure into complement
Lea, S. M., & Johnson, S. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.005 · Cited by 9
Update on therapeutic developments for hereditary angioedema
Christiansen, S. C., & Zuraw, B. L. (2009) · Allergy and Asthma Proceedings · doi:10.2500/aap.2009.30.3282 · Cited by 9
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Polyanion-induced self-association of complement factor H: possible mechanism of host protection from an innate immune system (53.11)
Pangburn, M. K., Rawal, N., Ferreira, V. P., & Atkinson, M. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.supp.53.11 · Cited by 2

Research works printed but not linked: 6

Holers VM, 1989, Year Immunol., 4, 231
Song JJ, 2011, J. Clin. Investig., 121, 3517
Rose KL, 2008, J. Clin. Investig., 118, 608
Calero I, 2010, Discov. Med., 10, 416
He S, 2009, J. Clin. Investig., 119, 2304
Thurman JM, J. Clin. Investig., 123, 2103

Sorted by citations

The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease
Lian, H., Yang, L., Cole, A., Sun, L., Chiang, A. C.-A., Fowler, S. W., Shim, D. J., Rodriguez-Rivera, J., Taglialatela, G., Jankowsky, J. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.018 · Cited by 697
Klebsiella pneumoniae infection biology: living to counteract host defences
Bengoechea, J. A., & Sá‐Pessoa, J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy043 · Cited by 605
The role of the complement system in cancer
Afshar‐Kharghan, V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90962 · Cited by 565

See all 430

Authors: Holers, V. M.
Affiliations: University of Colorado Anschutz (US)
Corresponding author: Holers, V. Michael
ORCID: Holers, V. Michael
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2014-03-21
Volume: 32
Issue: 1
Pages: 433-459
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev-immunol-032713-120154
OpenAlex: W2163243965
Cited by: 430
References: 152
Citations by year: 2026: 21 · 2025: 25 · 2024: 33 · 2023: 27 · 2022: 39 · 2021: 48 · 2020: 46 · 2019: 42 · 2018: 34 · 2017: 40 · 2016: 36 · 2015: 27 · 2014: 10
FWCI: 3.68
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: Lupus Research Alliance
National Institutes of Health
National Institute of Allergy and Infectious Diseases (R21AI105717)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR051749)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: complement system, complement receptors, complement activation, complement regulation, efferocytosis, bacterial infection, inflammatory diseases, autoimmune disease, degenerative diseases, rare diseases, genetic research, complement therapeutics, tissue damage
MeSH terms: Animals, Carrier Proteins, Complement System Proteins, Complement Activation, Disease Models, Animal, Disease Susceptibility, Humans, Protein Binding, Receptors, Complement, Signal Transduction, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Complement and Its Receptors: New Insights into Human Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks